Benztropine Mesylate

CAS 132-17-2 5 FDA-DMF suppliersSmall Molecule

Overview

Benztropine mesylate is an anticholinergic agent used to reduce extrapyramidal side effects associated with neuroleptic treatments and in the management of Parkinson's disease. It works by blocking acetylcholine receptors, hence balancing neurotransmitters to alleviate symptoms.

API suppliers (3)

Suppliers of Benztropine Mesylate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • FINE CHEMICALS CORP PTY LTD1 active DMF
  • FINE CHEMICALS CORP PTY LTD1 active DMF
  • Orion CorporationFinland

Therapeutic areas

NeurologyMovement Disorders

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.